Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy

Virotherapy on the basis of oncolytic vaccinia virus (VACV) strains is a novel approach for canine cancer therapy. Here we describe, for the first time, the characterization and the use of VACV strain GLV-5b451 expressing the anti-vascular endothelial growth factor (VEGF) single-chain antibody (scAb...

Descripción completa

Detalles Bibliográficos
Autores principales: Adelfinger, Marion, Bessler, Simon, Frentzen, Alexa, Cecil, Alexander, Langbein-Laugwitz, Johanna, Gentschev, Ivaylo, Szalay, Aladar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517140/
https://www.ncbi.nlm.nih.gov/pubmed/26205404
http://dx.doi.org/10.3390/v7072811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517140/
https://www.ncbi.nlm.nih.gov/pubmed/26205404
http://dx.doi.org/10.3390/v7072811

Ejemplares similares